Tianjin Tianyao Pharmaceuticals , Ltd. Receivables

Tianjin Tianyao Pharmaceuticals , Ltd. (600488.SS) currently reports a receivables of $780M as of June 2026. That compares with $710M in the prior-year period — up 10.9% year over year. Use the charts on this page to explore Tianjin Tianyao Pharmaceuticals , Ltd.'s receivables history and peer comparisons.

Tianjin Tianyao Pharmaceuticals , Ltd.'s receivables increased from $710M to $780M — a 10.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Tianjin Tianyao Pharmaceuticals , Ltd. reported $780M in receivables as of June 2026. That compares with $710M in the prior-year period — up 10.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $780M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tianjin Tianyao Pharmaceuticals , Ltd., and consider following 600488.SS for alerts when major investors trade the stock.